PRF1 and neoplasm: Flow cytometry analysis of tumor‐infiltrating CD8+ T cells revealed that cotreatment with V‐9302 and anti‐PD‐1 significantly enhanced the expression of cytolytic proteins (GZMB and PRF1) and effector cytokines (IFN‐γ and TNF‐α) compared to monotherapy groups.